Stock TradingBiotech Stocks Surge Double Digits as Regulatory Clarity Returns to the FDA
Gene therapy and rare disease stocks rally sharply as an FDA leadership transition signals a more predictable approval environment — uniQure jumps 36%, Biohaven gains 23%.
Jake Trader★Mar 9, 2026★4 min read
